<DOC>
	<DOCNO>NCT00256698</DOCNO>
	<brief_summary>The purpose study determine efficacy anastrozole monotherapy versus maximal oestrogen blockade combinated therapy fulvestrant anastrozole compare treatment hormone receptor positive woman first relapse breast cancer .</brief_summary>
	<brief_title>Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole Fulvestrant Combination Therapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Signed informed consent , postmenopausal female , histological cytological confirm oestrogene and/or progesterone ( PgR ) receptor positive breast cancer , local recurrence metastasis Previous systemic endocrine therapy advance recurrent disease ; prior fulvestrant therapy Premenopausal woman</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Hormone</keyword>
	<keyword>receptor</keyword>
	<keyword>positive</keyword>
	<keyword>breast</keyword>
	<keyword>cancer</keyword>
	<keyword>first</keyword>
	<keyword>relapse</keyword>
</DOC>